Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New Pain Test that Stratifies Patients for Optimal Therapy Seeks Partners

Published: Tuesday, February 19, 2013
Last Updated: Monday, February 18, 2013
Bookmark and Share
Algotect device measures an increased pain response to a cold stimulus.

A novel patented technology (Algotect) has been developed to accurately identify patients who are cold hyperalgesic and require specific pain management.

A recent Australian clinical trial (n=80) conducted with funding from a multi-national pharmaceutical company clearly segmented a group of knee osteoarthritis patients into those that had more pain, more disability, more widespread hyperalgesia and more neuropathic pain symptoms.

This group did not respond well to a standard non-steroidal medication. Cold hyperalgesic groups have been identified for a range of painful conditions and it is likely that these patients require more specific pain management.

More than 1.5 billion people worldwide suffer from chronic pain (American Academy of Pain Medicine) and around 100 million Americans suffer chronic pain (Institute of Medicine of the National Academies).

In developed countries about 30-40% of the population suffer pain from musculoskeletal and joint disorders plus an additional 30% suffer neck and back pain (International Association for the Study of Pain).

A chronic pain survey by the American Pain Foundation in 2006 (n=303) revealed 51% had little or no control over their pain and 59% reported an impact on their quality of life. The Algotect device identifies those most at risk of poor outcomes.

Managing Director and co-founder Prof Tony Wright comments, “There is an unmet medical need for a simple diagnostic test such as Algotect. Determining early on those patients who will develop chronic pain and providing them with more effective treatment will generate significant health outcomes for individuals and reduce costs on a global scale.”

The Algotect device measures an increased pain response to a cold stimulus (cold hyperalgesia). Patients who have cold hyperalgesia have more pain and more disability than others.

The prototype uses a transdermal patch that activates TRPM8 receptors in peripheral tissues over a 10-minute period. Patients indicate their sensory response via a computer interface.

A patented algorithm quantifies the sensory response and delivers a scored report indicating if their pain can be managed effectively through simple analgesics or if more comprehensive pain management is required.

Algometron seeks partners interested in commercially developing the innovative device, which provides real time, cost effective information to support clinicians, researchers, drug development and clinical trials.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,900+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
BGI Sequences Gingko Tree, Revealing Large, Highly Repetitive Genome
Researchers at BGI have sequenced the more than 10-gigabase ginkgo genome to find a high number of repetitive sequences as well as a number of gene clusters that appear to be involved in defense mechanisms.
Survey of New York City Soil Uncovers Medicine-Making Microbes
Microbes have long been an invaluable source of new drugs. And to find more, we may have to look no further than the ground beneath our feet.
Accelerating the Detection of Foodborne Bacterial Outbreaks
The speed of diagnosis of foodborne bacterial outbreaks could be improved by a new technique developed by researchers at the Georgia Institute of Technology.
Making Personalized Medicine a Reality
Groundbreaking technique developed at McMaster University is helping to pave the way for advances in personalized medicine.
Scientists Identify Unique Genomic Features in Testicular Cancer
The findings may shed light on factors in other cancers that influence their sensitivity to chemotherapy.
Top 10 Life Science Innovations of 2016
2016 has seen the release of some truly innovative products. To help you digest these developments, The Scientist have listed their top picks for the year.
BioCision Forms MedCision
The new company will focus on technologies for the management and automation of vital clinical processes.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!